A Pharmacokinetic and Safety Study of Risperidone Long Acting Injectable in Schizophrenic Patients
Clinical trial NCT00653406 · COMPLETED
Trial details
- NCT number
- NCT00653406
- Sponsor
- Janssen Pharmaceutical K.K.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2002-11-01
- Enrollment
- 29
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.